168 related articles for article (PubMed ID: 31298421)
1. No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study.
Jairath V; Hokkanen SRK; Guizzetti L; Boxall N; Campbell-Hill S; Patel H
Aliment Pharmacol Ther; 2019 Aug; 50(4):416-424. PubMed ID: 31298421
[TBL] [Abstract][Full Text] [Related]
2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
van Staa TP; Card T; Logan RF; Leufkens HG
Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Inflammatory Bowel Disease in Greenland.
Gantzel RH; Vesterdal JD; Haase AM; Petersen AJ; Grønbæk H; Pedersen ML
Inflamm Bowel Dis; 2023 Dec; 29(12):1879-1885. PubMed ID: 36702537
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
8. Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.
Shivashankar R; Tremaine WJ; Harmsen WS; Loftus EV
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):857-863. PubMed ID: 27856364
[TBL] [Abstract][Full Text] [Related]
9. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.
Ma C; Dutton SJ; Cipriano LE; Singh S; Parker CE; Nguyen TM; Guizzetti L; Gregor JC; Chande N; Hindryckx P; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2018 Jul; 48(2):114-126. PubMed ID: 29851091
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Cappello M; Licata A; Calvaruso V; Bravatà I; Aiello A; Torres D; Della Corte V; Tuttolomondo A; Perticone M; Licata G; Craxì A; Cammà C
Eur J Intern Med; 2017 Jan; 37():83-89. PubMed ID: 27773555
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ
Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041
[TBL] [Abstract][Full Text] [Related]
13. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
[TBL] [Abstract][Full Text] [Related]
14. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
15. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
Burisch J; Zammit SC; Ellul P; Turcan S; Duricova D; Bortlik M; Andersen KW; Andersen V; Kaimakliotis IP; Fumery M; Gower-Rousseau C; Girardin G; Valpiani D; Goldis A; Brinar M; Čuković-Čavka S; Oksanen P; Collin P; Barros L; Magro F; Misra R; Arebi N; Eriksson C; Halfvarson J; Kievit HAL; Pedersen N; Kjeldsen J; Myers S; Sebastian S; Katsanos KH; Christodoulou DK; Midjord J; Nielsen KR; Kiudelis G; Kupcinskas L; Nikulina I; Belousova E; Schwartz D; Odes S; Salupere R; Carmona A; Pineda JR; Vegh Z; Lakatos PL; Langholz E; Munkholm P;
J Gastroenterol Hepatol; 2019 Jun; 34(6):996-1003. PubMed ID: 30562421
[TBL] [Abstract][Full Text] [Related]
16. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
17. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
[TBL] [Abstract][Full Text] [Related]
18. Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
Campbell S; Ghosh S
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1297-301. PubMed ID: 11692054
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
[TBL] [Abstract][Full Text] [Related]
20. Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease.
Yao LY; Shao BL; Tian F; Ye M; Li YQ; Wang XL; Wang L; Yang SQ; Lv XP; Jia Y; Wang XH; Zhang XQ; Wei YL; Cao Q
World J Gastroenterol; 2022 Aug; 28(30):4102-4119. PubMed ID: 36157116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
